TCRT
Alaunos Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.42M
P/E Ratio
—
EPS
$-2.20
Beta
-1.13
52W High
$5.48
52W Low
$1.67
50-Day MA
$3.02
200-Day MA
$2.94
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
18.48
PEG Ratio
0.58
About Alaunos Therapeutics Inc
Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring, developing and commercializing a portfolio of immuno-oncology therapies to treat cancer patients. The company is headquartered in Houston, Texas.
Fundamentals
| Revenue (TTM) | 5,000 |
| Gross Profit (TTM) | $-1.36M |
| EBITDA | $-4.22M |
| Operating Margin | -30233.00% |
| Return on Equity | -198.10% |
| Return on Assets | -92.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.27 |
| Price-to-Book | 3.05 |
| Price-to-Sales (TTM) | 1284.26 |
| EV/Revenue | 1035.8 |
| EV/EBITDA | -3.54 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -25.00% |
| Shares Outstanding | $2.38M |
| Float | $1.89M |
| % Insiders | 4.10% |
| % Institutions | 5.97% |
Historical Volatility
HV 10-Day
33.44%
HV 20-Day
38.42%
HV 30-Day
39.27%
HV 60-Day
56.76%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/28/2026